183 related articles for article (PubMed ID: 36074221)
21. Clinical and pathological predictors of relapse in IgG4-related disease.
Zongfei J; Lingli C; Ying S; Lingying M; Lijuan Z; Dongmei L; Xiaomin D; Yingyong H; Huiyong C; Lili M; Lindi J
Arthritis Res Ther; 2022 May; 24(1):106. PubMed ID: 35546243
[TBL] [Abstract][Full Text] [Related]
22. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Zhang P; Gong Y; Liu Z; Liu Y; Lin W; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Li Y; Zhao Y; Zhang W
Int J Rheum Dis; 2019 Aug; 22(8):1479-1488. PubMed ID: 31245907
[TBL] [Abstract][Full Text] [Related]
24. Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial.
Peng L; Nie Y; Zhou J; Wu L; Chen X; Wang F; Li J; Peng Y; Lu H; Zhao L; Li M; Zhao Y; Zeng X; Fei Y; Zhang W
Ann Rheum Dis; 2024 Apr; 83(5):651-660. PubMed ID: 38216319
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study.
Peng L; Lu H; Zhou J; Zhang P; Li J; Liu Z; Wu D; Zhang S; Yang Y; Bai W; Wang L; Fei Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2021 Apr; 23(1):102. PubMed ID: 33827676
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease.
Liu Y; Zhang Y; Bian W; Fu J; Sun X; Chen D; Chen J; Zhao X; Li Y; Zhang W; Li Z
Clin Rheumatol; 2020 Feb; 39(2):491-497. PubMed ID: 31848912
[TBL] [Abstract][Full Text] [Related]
27. Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease.
Choi SJ; Ahn SM; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
PLoS One; 2023; 18(3):e0282852. PubMed ID: 36893163
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoids in the treatment of IgG4-related disease-Prospects for new international treatment guidelines.
Yoshifuji H; Umehara H
Mod Rheumatol; 2023 Mar; 33(2):252-257. PubMed ID: 35993488
[TBL] [Abstract][Full Text] [Related]
29. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease.
Phaopraphat K; Ngamjanyaporn P; Narongroeknawin P; Kasitanon N; Katchamart W
Int J Rheum Dis; 2020 Nov; 23(11):1468-1473. PubMed ID: 32808722
[TBL] [Abstract][Full Text] [Related]
30. Identification of galectin-3 as an autoantigen in patients with IgG
Perugino CA; AlSalem SB; Mattoo H; Della-Torre E; Mahajan V; Ganesh G; Allard-Chamard H; Wallace Z; Montesi SB; Kreuzer J; Haas W; Stone JH; Pillai S
J Allergy Clin Immunol; 2019 Feb; 143(2):736-745.e6. PubMed ID: 29852256
[TBL] [Abstract][Full Text] [Related]
31. Increased Circulating Th1 and Tfh1 Cell Numbers Are Associated with Disease Activity in Glucocorticoid-Treated Patients with IgG4-Related Disease.
Xia C; Liu C; Liu Y; Long Y; Xu L; Liu C
J Immunol Res; 2020; 2020():3757015. PubMed ID: 33313326
[TBL] [Abstract][Full Text] [Related]
32. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
Liu Y; Zeng Q; Zhu L; Gao J; Wang Z; Wang Z; Yang F; Wang K; Chen D; Xia C; Zhang S; Wang Y; Shen D; Yu G; Li ZG
Rheumatology (Oxford); 2020 Aug; 59(8):2115-2123. PubMed ID: 32097488
[TBL] [Abstract][Full Text] [Related]
33. The association of different serum IgG4 levels with distinct clinical characteristics and treatment efficacy in patients with IgG4-related disease.
Zhang P; Liu Z; Li J; Fei Y; Wang X; Wang M; Zhu L; Xue H; Feng R; Hu C; Zhang S; Zhang W; Zhao Y; Zeng X; Zhang F
Clin Exp Rheumatol; 2021; 39(4):727-735. PubMed ID: 34238402
[TBL] [Abstract][Full Text] [Related]
34. The Significance of Serum IgG4/IgG and IgG4/IgG1 Ratio in the Diagnosis Value of IgG4-Related Diseases.
Wang W; Li Y; Feng H
Discov Med; 2023 Aug; 35(177):476-482. PubMed ID: 37553301
[TBL] [Abstract][Full Text] [Related]
35. Prediction of new organ onset in recurrent immunoglobulin G4-related disease during 10 years of follow-up.
Liu Z; Peng Y; Li J; Lu H; Peng L; Zhou J; Zhou S; Huang C; Wang M; Zhu L; Chen H; Wang L; Fei Y; Zhao Y; Zeng X; Zhang W
J Intern Med; 2022 Jul; 292(1):91-102. PubMed ID: 35419810
[TBL] [Abstract][Full Text] [Related]
36. B-cells depletion after treatment with rituximab predicts relapse of IgG4-related disease.
Lanzillotta M; Ramirez GA; Milani R; Dagna L; Della-Torre E
Rheumatology (Oxford); 2024 May; ():. PubMed ID: 38781535
[TBL] [Abstract][Full Text] [Related]
37. Pathogenic roles of follicular helper T cells in IgG4-related disease and implications for potential therapy.
Xu J; Zhai J; Zhao J
Front Immunol; 2024; 15():1413860. PubMed ID: 38911857
[TBL] [Abstract][Full Text] [Related]
38. Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related disease.
Della-Torre E; Lanzillotta M; Germanò T; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L
Semin Arthritis Rheum; 2021 Aug; 51(4):761-765. PubMed ID: 34144386
[TBL] [Abstract][Full Text] [Related]
39. Pathological count of IgG4-positive plasmacytes suggests extraophthalmic involvement and relapse in patients with IgG4-related ophthalmic disease: a retrospective study.
Yuan Y; Meng F; Ren H; Yue H; Xue K; Zhang R
Arthritis Res Ther; 2022 Apr; 24(1):80. PubMed ID: 35365184
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin G4-Related Disease Responder Index Correlates With the Risk of 1-Year Relapse in Type 1 Autoimmune Pancreatitis.
Rogger TM; De Marchi G; Brozzi L; Amodio A; Orsolini G; de Pretis N; Conti Bellocchi MC; Crinò SF; Gabbrielli A; Ciccocioppo R; Frulloni L
Pancreas; 2021 Jul; 50(6):879-881. PubMed ID: 34347736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
